There is a growing demand for healing. In the world in 2018, there are several hundred million people who suffer from various diseases such as the elderly, sickness and accidents.
In order to solve all these problems, investors have launched the CURAIZON project. This project will help patients take medication properly
What does the company do?
We aim to improve drug adherence and bring game-changing benefits to patients and healthcare providers by being the leading supplier of adherence and data solutions worldwide.
What is unique about the company?
Our solution works with patients, their families and healthcare providers to ensure that patients take their medications as prescribed through a series of outreach tools, supported by predictive modeling tools and behavioural analysis, to increase the rate of drug adherence
What problem does the company solve?
Our CuraServe technology helps ensure that patients take their medicines as prescribed by their doctor. By doing this, we help patients live longer and healthier lives. We also reduce the healthcare costs that occur when patients fail to take their medications properly.
How do you create value to support your CuraTokens?
Our CuraServe™ technology generates a tremendous amount of unique, real-time data showing how people take their medications that is very valuable to a variety of groups including pharmaceutical companies, medical researchers and biotech companies. CuraTokens™ allow token owners access to the data to make queries. As our solution is rolled out to more and more patients in more and more countries. The more data we generate, the more valuable that CuraTokens™ become.
Who are your target customers?
Curaizon™ sells its adherence (CuraServe™) solutions to national health services around the world. Our end users are the health service's patients who take any form of medication. We also work with academia, pharmaceutical and biotech industries, as well as other users of data via our CuraData™ solution.
What is your geographic target market?
Curaizon targets countries with national health services. This currently includes 1.4 Billion people and that number is growing.
What are the potentials of the market?
The global cost of non-adherence is over €600 billion each year and results in hundreds of thousands of lives lost prematurely. Adherence for chronic and long-term illness is less than 50%.
HERE IS ALL THE QUESTIONS THAT THE PROJECT HAS ESTABLISHED TO INTEGRATE ALL YOUR FEEDBACK ON THE PROJECT.
Token review
CuraToken (CTKN), it is a token of the standard egip‐20 on Ethereum, which can be used to access data on medical adherence through the platform CuraData.
CuraToken Pre-Sale: June 1, 2018 - June 8, 2018
CuraToken Public Sale: June 8, 2018 – September 8, 2018
Softcap : 1,000,000 USD
Hardcap : 25,000,000 USD
Coins for Sale : 250,000,000
Coin Price : 0.2 USD
ROADMAP
TEAM
Conclude:
This is a pretty interesting project. I have explored a lot of projects about cure and medication, but I feel that the CURAIZON project is a very evolving project, because the safeguards will make the patient feel more secure. when to use it
For more information about Curaizon
Website: https://curatoken.curaizon.com/
Whitepaper: https://curatoken.curaizon.com/wp-content/themes/curatoken/White_paper.pdf
Litepaper: https://curatoken.curaizon.com/wp-content/themes/curatoken/Lite_paper.pdf
ANN Thread: https://bitcointalk.org/index.php?topic=4401662.0
Youtube: https://www.youtube.com/channel/UCjNZcxOvYCQSyyXXYPRrbRQ
Telegram: https://t.me/joinchat/ILiK_Q7VBLOByz_7mMUgsQ
Linkedin: https://www.linkedin.com/company/curaizon-ltd
Twitter: https://twitter.com/curaizon
Facebook: https://www.facebook.com/curaizonltd/
DETAILS:
Bitcointalk username: anchuoinhhoc
Ether address: 0x8F541BFb400a9a3E3bD6a8cF45Fe0E9c5450582E
Bitcointalk URL: https://bitcointalk.org/index.php?action=profile;u=2200627
Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:
https://curatoken.curaizon.com/